Clinical Practice Guideline

Diagnosis and Treatment of Pheochromocytoma and Paraganglioma

June 19, 2014

Full Guideline: Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
JCEM June 2014

Jacques W. M. Lenders, Quan-Yang Duh, Graeme Eisenhofer, Anne-Paule Gimenez-Roqueplo, Stefan K. G. Grebe, Mohammad Hassan Murad, Mitsuhide Naruse, Karel Pacak, William F. Young, Jr.

Objective:

The aim was to formulate clinical practice guidelines for pheochromocytoma and paraganglioma (PPGL).

Conclusions:

  • The Task Force recommends that initial biochemical testing for PPGLs should include measurements of plasma free or urinary fractionated metanephrines.
  • Consideration should be given to preanalytical factors leading to false-positive or false-negative results.
  • All positive results require follow-up.
  • Computed tomography is suggested for initial imaging, but magnetic resonance is a better option in patients with metastatic disease or when radiation exposure must be limited.
  • I-metaiodobenzylguanidine scintigraphy is a useful imaging modality for metastatic PPGLs.
  • We recommend consideration of genetic testing in all patients, with testing by accredited laboratories.
  • Patients with paraganglioma should be tested for SDHx mutations, and those with metastatic disease for SDHB mutations.
  • All patients with functional PPGLs should undergo preoperative blockade to prevent perioperative complications.
  • Preparation should include a high-sodium diet and fluid intake to prevent postoperative hypotension.
  • We recommend minimally invasive adrenalectomy for most pheochromocytomas with open resection for most paragangliomas.
  • Partial adrenalectomy is an option for selected patients.
  • Lifelong follow-up is suggested to detect recurrent or metastatic disease.
  • We suggest personalized management with evaluation and treatment by multidisciplinary teams with appropriate expertise to ensure favorable outcomes.

arrow Read the Full Guideline

Clinical Practice Guidelines

CPG Pocket Guides

Clinical Practice Guidelines Pocket Guides
Practical quick-reference tools to help you make accurate clinical decisions at the point of care.
Clinical Practice Guidelines

CPG Pocket Guides

Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Download our CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.